COVID-19 vaccine from new vaccine platform effective in mice

February 04, 2021

It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically. Researchers at Karolinska Institutet in Sweden now report that they have developed a prototype vaccine against SARS-CoV-2 using a DNA vaccine platform that is inexpensive, stable, easy to produce, and shows a good safety profile. A study published in Scientific Reports shows that the vaccine induces potent immune responses in mice.

The vaccine, called DREP-S, is administered as DNA and is based on a DNA-launched self-amplifying RNA (DREP) platform developed at Karolinska Institutet. This means that upon delivery into host cells, the vaccine will launch an RNA replicon, which is a self-amplifying RNA molecule that produces multiple copies of a selected RNA sequence.

The platform has previously been used to develop several vaccines that are now in clinical trials towards infectious viral diseases such as HIV, Ebola, chikungunya and HPV. It is also inexpensive, stable and easy to produce. Its self-amplification feature enables administration of lower doses and consequently might induce milder side effects, according to the researchers. Two other advantages are that it does not require a cold chain during transportation and storage and that it is suitable for rapid adaptation to new virus variants.

The vaccine carries the gene encoding the external spike (S) protein of SARS-CoV-2 and was developed by Dr Inga Szurgot in Professor Peter Liljestrom's lab and colleagues in Gerald McInerney's lab at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet.

"Although several vaccines against COVID-19 have been approved for emergency use, there are still concerns regarding the durability of immune responses after vaccination," says first author Inga Szurgot. "Moreover, the vaccines that are based on mRNA molecules need to be stored and transported at ultralow temperatures. Maintaining such conditions can cause logistical problems and might not even be possible in many areas of the world where the need for vaccines is great."

In the new study, the researchers were able to show that the DREP-S vaccine is immunogenic in mice, generating high levels of SARS-CoV-2-specific IgG antibodies as well as very strong T cell responses. Importantly, the vaccine-induced antibodies were able to efficiently neutralize SARS-CoV-2 virus after a single immunization. In addition, the researchers reported that a second vaccination with a different vaccine type, containing recombinant SARS-CoV-2 spike protein resulted in even better immune responses.

"Different vaccine approaches and platforms have their distinct merits and may work synergistically in regimens where a patient receives first immunization with one type of vaccine and second with a different type," says last author Peter Liljestrom. "This approach often gives a better response and should be investigated further."
The study was financed by the Swedish Research Council, the Development Office at Karolinska Institutet and the European Union's Horizon 2020 research and innovation program. The authors declare no conflict of interest.

Publication: "DNA-launched RNA Replicon Vaccines Induce Potent anti-SARS2 CoV-2 Immune Responses in Mice". Inga Szurgot, Leo Hanke, Daniel J. Sheward, Laura Perez Vidakovics, Ben Murrell, Gerald M. McInerney and Peter Liljestrom. Scientific Reports, online 4 February 2021, doi: 10.1038/s41598-021-82498-5.

Karolinska Institutet

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to